Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus

Clin Transl Oncol. 2023 Apr;25(4):1017-1023. doi: 10.1007/s12094-022-03005-4. Epub 2022 Nov 27.

Abstract

Background: To reach a consensus on recommendations for the management of high-risk and post-operative non-metastatic prostate cancer by a group of Radiation Oncologists in Catalonia dedicated to prostate cancer.

Methods: A modified Delphi approach was employed to reach consensus on controversial topics in Radiation Oncology on high-risk non-metastatic (eight questions) and post-operative (eight questions) prostate cancer. An agreement of at least 75% was considered as consensus. The survey was electronically sent 6 weeks before an expert meeting where topics were reviewed and discussed. A second-round survey for the controversial questions only was sent and answered by participants after the meeting.

Results: After the first round of the survey, 19 experienced Radiation Oncologists attended the meeting and 74% fulfilled the second-round online questionnaire. An agreement of 9 of the 16 questions was accounted for the first round. After the meeting, an additional agreement was reached in 3 questions leading to a final consensus on 12 of the 16 questions. There are still controversial topics like the use of PET for staging of high-risk and post-operative non-metastatic prostate cancer and the optimal dose to the prostate bed in the salvage setting.

Conclusion: This consensus contributes to establish recommendations and a framework to help in prostate cancer radiation therapy and pharmacological management in daily clinical practice of high-risk and post-operative non-metastatic prostate cancer.

Keywords: Delphi consensus; High-risk; Non-metastatic; Prostate cancer.

MeSH terms

  • Consensus
  • Delphi Technique
  • Humans
  • Male
  • Prostatic Neoplasms* / therapy
  • Spain
  • Surveys and Questionnaires